Sunday, July 5, 2026

Pharmaceutical Calculators · Formulation & Lab

Buffer pH Calculator: Henderson-Hasselbalch

Calculate buffer pH from pKa and acid/base concentrations, find the conjugate-base-to-acid ratio for a target pH, or back-calculate pKa from measurements. Built for IV and ophthalmic formulation, biologics stability, and analytical buffer prep — then verify with pH meter and osmolarity checks.

Quick Answer

Buffer pH follows the Henderson-Hasselbalch equation: pH = pKa + log₁₀([A⁻]/[HA]). Pharmaceutical formulators use it to select buffer systems (phosphate, acetate, citrate, HEPES) whose pKa sits within ±1 unit of the target pH for IV, ophthalmic, and biologics stability studies. This calculator solves for pH, required base/acid ratio, or pKa — then verify isotonicity with the Osmolarity Calculator and mass prep with the Molarity Calculator.

Henderson-Hasselbalch Equation
pH = pKa + log10([A]/[HA])
[A] = conjugate base concentration    [HA] = weak acid concentration
Rearrangements:
[A]/[HA] = 10(pH − pKa)     pKa = pH − log10([A]/[HA])

Buffer pH Calculator

Select a mode and enter pKa, concentrations, or target pH to calculate buffer pH or required acid/base ratio.

Acid and base concentrations
Calculated pH
[A−]/[HA] Ratio
Target pH and pKa
[A−]/[HA] Ratio
Preparation
Measured pH and concentrations
Calculated pKa

Common Pharmaceutical Buffer Reference

Click any row to auto-populate the pKa field in the calculator above.

Buffer System pKa Useful pH Range Common Use
Citric acid / Sodium citrate 3.13, 4.76, 6.40 3.0–6.2 Oral liquids, topical
Acetic acid / Sodium acetate 4.76 3.8–5.8 Parenteral, ophthalmic
Phosphate (monobasic/dibasic) 7.20 5.8–8.0 Parenteral, cell culture
Tris (TRIS) 8.06 7.0–9.0 Biochemistry, lab buffers
Boric acid / Sodium borate 9.24 8.0–10.0 Ophthalmic
Carbonate / Bicarbonate 10.33 9.2–10.8 Physiological buffers
HEPES 7.55 6.8–8.2 Cell culture media
MES 6.15 5.5–6.7 Lab buffers
MOPS 7.20 6.5–7.9 Lab buffers

How to Use

1
Select your calculation mode: Calculate pH (from pKa and concentrations), Calculate Ratio (for a target pH), or Calculate pKa (from measurements).
2
Enter the required values, or click any row in the buffer reference table to automatically populate the pKa field.
3
Click Calculate to compute the result.
4
The buffer effectiveness indicator shows whether your pH is within the optimal buffer range (pKa ± 1 unit).

Worked Example

Phosphate Buffer pH 7.4

pKa = 7.20, Target pH = 7.4

Ratio = 10(7.4 − 7.2) = 100.2 = 1.585

Add 1.585 parts dibasic phosphate to 1 part monobasic phosphate.

Since |7.4 − 7.2| = 0.2 < 1.0, this is within the optimal buffer range.

Pharma & formulation context

Buffer selection is a core step in parenteral and biologics formulation development, compounding SOPs, and analytical method buffers for HPLC and ELISA. Sponsors document target pH, buffer species, ionic strength, and compatibility with the API under ICH Q1A stability protocols — pH drift outside specification can trigger degradation pathways or precipitation.

After estimating pH or base/acid ratio here, calculate component masses with the Molarity Calculator, verify tonicity with the Osmolarity Calculator, and adjust dilutions with the Dilution Calculator. IV infusion rate planning links to the IV Drip Rate Calculator; concentration unit checks use the Unit Converter.

Release testing requires pH measurement on the finished solution — not calculation alone. Document meter calibration, temperature, and specification limits in the batch record. For ophthalmic products, target pH near tear fluid (~7.4) and isotonicity (~300 mOsm/L) to minimise stinging and corneal stress.

Evidence & sources

Frequently Asked Questions

The Henderson-Hasselbalch equation relates pH, pKa, and the ratio of conjugate base to weak acid: pH = pKa + log([A⁻]/[HA]). It is the fundamental equation for buffer pH in pharmaceutical formulation, analytical method development, and cell-culture media design. Rearrangements solve for ratio ([A⁻]/[HA] = 10^(pH − pKa)) or pKa (pKa = pH − log([A⁻]/[HA])).
A buffer resists pH change most effectively within ±1 pH unit of its pKa. Outside this range, one form dominates and buffering capacity drops sharply. For maximum capacity at a fixed total buffer concentration, choose a buffer whose pKa is closest to your target pH — for example phosphate (pKa 7.2) for physiological pH 7.4, or acetate (pKa 4.76) for acidic oral liquids.
Phosphate buffer (pKa ~7.2) is widely used in parenteral formulations because it brackets physiological pH (7.4) and can be prepared isotonic with sodium chloride adjustment. Citrate and acetate appear in smaller-volume injections; HEPES and Tris are common in biologics and cell-culture contexts but are not always approved for all parenteral routes — confirm excipient status in regional pharmacopeias.
Buffer capacity (β) is the moles of strong acid or base required to change pH by one unit — it quantifies resistance to pH drift. Buffer range is the pH interval where the buffer remains useful, typically pKa ± 1. Maximum β occurs when pH = pKa and [A⁻] = [HA]. Higher total buffer concentration increases β but may affect tonicity and regulatory acceptability for injectables.
An isotonic solution exerts osmotic pressure similar to blood plasma (~285–295 mOsm/kg; 0.9% NaCl ≈ 308 mOsm/L). IV buffers must be near-isotonic to avoid haemolysis (hypotonic) or vein irritation (hypertonic). After calculating pH here, use the Osmolarity Calculator to sum solute contributions and classify tonicity before batch release or compounding.
Match buffer pKa to the target formulation pH within ±1 unit, confirm excipient compatibility with the API (degradation, precipitation, metal chelation), and verify regulatory acceptance for the route (oral, parenteral, ophthalmic). Phosphate can form insoluble complexes with calcium; citrate chelates metals; acetate has odor limits. Stability protocols should bracket the chosen pH ± 0.5 under ICH Q1A conditions.
The equation uses activities, not just concentrations. At high ionic strength (high salt, multivalent ions), activity coefficients deviate from ideal behaviour and measured pH may differ from calculated pH by 0.1–0.3 units or more. For critical parenteral formulations, confirm pH by calibrated pH meter at process temperature rather than relying on calculation alone.
Use pKa 7.20 and target pH 7.40: ratio [A⁻]/[HA] = 10^(7.4 − 7.2) = 1.585. Mix 1.585 parts dibasic phosphate to 1 part monobasic phosphate (by mole or equivalent mass per MW). Dissolve in water, adjust to final volume, measure pH, and verify osmolarity. This calculator’s Ratio mode returns the same result with a preparation hint.
pKa applies to weak acids and their conjugate bases (pH = pKa + log([A⁻]/[HA])). Weak bases use pKb and pOH = pKb + log([BH⁺]/[B]), then pH = 14 − pOH at 25 °C. Tris and other amine buffers are often handled as base buffers. This tool focuses on the acid/conjugate-base form used in most pharma phosphate, acetate, and citrate systems.
Henderson-Hasselbalch uses the ratio of conjugate base to acid, not absolute molarity — but you need correct mM concentrations to weigh components. Calculate masses with the Molarity Calculator (Mass = M × V × MW), then apply this tool for pH or ratio. For multi-component formulations, also check total osmolarity with the Osmolarity Calculator.
Always measure pH for release testing, batch records, and patient-facing parenteral products. Calculation is appropriate during early formulation design, method development, and education. Temperature, CO₂ exposure (bicarbonate buffers), and ionic strength shift measured pH — document meter calibration, electrode type, and sample temperature per USP ⟨791⟩.
No. Pharmacopeial monographs and approved master formulas specify exact components, concentrations, and preparation steps. This tool supports estimation and training; GMP batches require qualified methods, approved specifications, and pH verification on the final solution. Confirm excipient limits and buffer strength against USP, Ph. Eur., or FDA inactive ingredient guidance.

Related Calculators